Rosemary A. Walker

4.0k total citations
72 papers, 2.8k citations indexed

About

Rosemary A. Walker is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Rosemary A. Walker has authored 72 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 30 papers in Oncology and 23 papers in Cancer Research. Recurrent topics in Rosemary A. Walker's work include HER2/EGFR in Cancer Research (18 papers), Glycosylation and Glycoproteins Research (16 papers) and Monoclonal and Polyclonal Antibodies Research (13 papers). Rosemary A. Walker is often cited by papers focused on HER2/EGFR in Cancer Research (18 papers), Glycosylation and Glycoproteins Research (16 papers) and Monoclonal and Polyclonal Antibodies Research (13 papers). Rosemary A. Walker collaborates with scholars based in United Kingdom, United States and Japan. Rosemary A. Walker's co-authors include J. Louise Jones, Jacqui Shaw, Sheila J. Dearing, Jennifer M. Varley, David R. Critchley, James H. Pringle, Matthew Adams, P. V. Senior, Alonso Martínez and Eamonn R. Maher and has published in prestigious journals such as Development, Oncogene and Genome Research.

In The Last Decade

Rosemary A. Walker

70 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rosemary A. Walker United Kingdom 31 1.5k 1.0k 720 383 340 72 2.8k
Colette Charpin France 36 1.7k 1.1× 1.7k 1.7× 1.3k 1.8× 526 1.4× 441 1.3× 135 3.8k
Joan Levy United States 28 2.6k 1.7× 955 1.0× 406 0.6× 250 0.7× 397 1.2× 58 3.6k
Antoninus Soosaipillai Canada 38 1.3k 0.9× 1.1k 1.1× 604 0.8× 240 0.6× 304 0.9× 91 3.6k
Eric H. Westin United States 28 2.2k 1.4× 819 0.8× 397 0.6× 631 1.6× 184 0.5× 66 3.6k
Nancy Dumont United States 23 2.5k 1.7× 1.9k 1.9× 735 1.0× 222 0.6× 276 0.8× 32 3.9k
Michael Reedijk Canada 33 2.4k 1.6× 1.4k 1.4× 731 1.0× 184 0.5× 192 0.6× 50 3.7k
Rosemarie Schmandt United States 32 2.7k 1.8× 1.1k 1.1× 1.3k 1.8× 334 0.9× 194 0.6× 65 4.6k
Serhiy Souchelnytskyi Sweden 31 3.2k 2.1× 896 0.9× 470 0.7× 296 0.8× 208 0.6× 110 4.1k
Sing Rong United States 16 2.1k 1.4× 798 0.8× 369 0.5× 285 0.7× 132 0.4× 23 3.2k
Isidro Sánchez‐García Spain 36 2.7k 1.8× 1.3k 1.3× 669 0.9× 322 0.8× 111 0.3× 115 4.4k

Countries citing papers authored by Rosemary A. Walker

Since Specialization
Citations

This map shows the geographic impact of Rosemary A. Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosemary A. Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosemary A. Walker more than expected).

Fields of papers citing papers by Rosemary A. Walker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosemary A. Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosemary A. Walker. The network helps show where Rosemary A. Walker may publish in the future.

Co-authorship network of co-authors of Rosemary A. Walker

This figure shows the co-authorship network connecting the top 25 collaborators of Rosemary A. Walker. A scholar is included among the top collaborators of Rosemary A. Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosemary A. Walker. Rosemary A. Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walker, Rosemary A., et al.. (2012). Current issues in diagnostic breast pathology. Journal of Clinical Pathology. 65(9). 771–785. 20 indexed citations
2.
Shaw, Emily, Andrew M. Hanby, Kevin Wheeler, et al.. (2012). Observer agreement comparing the use of virtual slides with glass slides in the pathology review component of the POSH breast cancer cohort study. Journal of Clinical Pathology. 65(5). 403–408. 26 indexed citations
3.
Guttery, David S., Simon Hughes, James H. Pringle, et al.. (2010). Association of invasion-promoting tenascin-C additional domains with breast cancers in young women. Breast Cancer Research. 12(4). R57–R57. 28 indexed citations
4.
Allen, Michael D., Michael R. Green, Claude Chelala, et al.. (2010). Clinical and functional significance of α9β1 integrin expression in breast cancer: a novel cell‐surface marker of the basal phenotype that promotes tumour cell invasion. The Journal of Pathology. 223(5). 646–658. 31 indexed citations
5.
Stotter, A. & Rosemary A. Walker. (2009). Tumour markers predictive of successful treatment of breast cancer with primary endocrine therapy in patients over 70 years old: A prospective study. Critical Reviews in Oncology/Hematology. 75(3). 249–256. 12 indexed citations
6.
Holliday, Deborah L., Simon Hughes, Jacqui Shaw, Rosemary A. Walker, & J. Louise Jones. (2007). Intrinsic genetic characteristics determine tumor-modifying capacity of fibroblasts: matrix metalloproteinase-3 5A/5A genotype enhances breast cancer cell invasion. Breast Cancer Research. 9(5). R67–R67. 40 indexed citations
7.
Page, Karen, Tom Powles, Martin J. Slade, et al.. (2006). The Importance of Careful Blood Processing in Isolation of Cell‐Free DNA. Annals of the New York Academy of Sciences. 1075(1). 313–317. 61 indexed citations
8.
Gordon, Linda, et al.. (2003). Breast cell invasive potential relates to the myoepithelial phenotype. International Journal of Cancer. 106(1). 8–16. 108 indexed citations
9.
Dallol, Ashraf, Éva Forgács, Alonso Martínez, et al.. (2002). Tumour specific promoter region methylation of the human homologue of the Drosophila Roundabout gene DUTT1 (ROBO1) in human cancers. Oncogene. 21(19). 3020–3028. 94 indexed citations
10.
Johnson, Suzanne M., Jacqui Shaw, & Rosemary A. Walker. (2001). Sporadic breast cancer in young women: Prevalence of loss of heterozygosity at p53, BRCA1 and BRCA2. International Journal of Cancer. 98(2). 205–209. 37 indexed citations
11.
Agathanggelou, Angelo, Sofia Honorio, Donia Macartney‐Coxson, et al.. (2001). Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene. 20(12). 1509–1518. 336 indexed citations
12.
Walker, Rosemary A., Sheila J. Dearing, & Louise Brown. (1999). Comparison of pathological and biological features of symptomatic and mammographically detected ductal carcinoma in situ of the breast. Human Pathology. 30(8). 943–948. 13 indexed citations
13.
Adams, Susan M., et al.. (1995). Loss of heterozygosity on the X chromosome in human breast cancer. Genes Chromosomes and Cancer. 13(4). 229–238. 22 indexed citations
14.
Rye, Philip D., et al.. (1995). Monoclonal antibody LU-BCRU-G7 against a breast tumour-associated glycoprotein recognizes the disaccharide Galβ1-3GlcNAc. Glycobiology. 5(4). 385–389. 32 indexed citations
15.
Walker, Rosemary A. & Sheila J. Dearing. (1992). Transforming growth factor beta1 in ductal carcinoma in situ and invasive carcinomas of the breast. European Journal of Cancer. 28(2-3). 641–644. 124 indexed citations
16.
Jones, J. Louise, David R. Critchley, & Rosemary A. Walker. (1992). Alteration of stromal protein and integrin expression in breast—a marker of premalignant change?. The Journal of Pathology. 167(4). 399–406. 62 indexed citations
17.
18.
Walker, Rosemary A. & Nafisa Wilkinson. (1988). p21 ras protein expression in benign and malignant. The Journal of Pathology. 156(2). 147–153. 19 indexed citations
19.
Jones, J. Louise & Rosemary A. Walker. (1987). The assessment of in vitro modulation of milk fat globule membrane expression by human breast carcinomas. The Journal of Pathology. 153(1). 51–60. 4 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Colette Charpin Breakdown of academic impact, for papers by Joan Levy Breakdown of academic impact, for papers by Antoninus Soosaipillai Breakdown of academic impact, for papers by Eric H. Westin Breakdown of academic impact, for papers by Nancy Dumont Breakdown of academic impact, for papers by Michael Reedijk Breakdown of academic impact, for papers by Rosemarie Schmandt Breakdown of academic impact, for papers by Serhiy Souchelnytskyi Breakdown of academic impact, for papers by Sing Rong Breakdown of academic impact, for papers by Isidro Sánchez‐García
Rankless by CCL
2026